| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005265 | Clinical Therapeutics | 2005 | 18 Pages |
Abstract
BIAsp 30 BID can reduce PPG levelsto a greater extent than other common treatment regimens, including basal insulin OD. Using BIAsp 30, even once daily, may allow some patients to reach glycemic targets with a degree of convenience and tolerability that may not be achievable with other treatment regimens.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
MD Halimi, MD Raskin, MD Liebl, MD Kawamori, MD Fulcher, MD Yan,